A Preclinical, Precision Medicine Approach Based on Retargeted Herpesviruses with Oncoimmunotherapeutic Potential (PreMeRetHOn)

Responsabile scientifico: prof.ssa Gianni Tatiana

Ente finanziatore: MUR

Durata: 16/10/2023 - 15/10/2025